LIQUID BIOPSY RES LLC has a total of 48 patent applications. Its first patent ever was published in 2018. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets biotechnology, pharmaceuticals and computer technology are ATHLOMICS PTY LTD, NAT INSTITUTE FOR COMMUNICABLE DISEASE CONTROL AND PREVENTION CHINESE CENTER FOR DISEASE CONTROL AND and BEIJING MEDINTELL BIOMED INFORMATION TECH CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | WIPO (World Intellectual Property Organization) | 6 | |
#3 | Australia | 5 | |
#4 | Brazil | 5 | |
#5 | Canada | 5 | |
#6 | EPO (European Patent Office) | 5 | |
#7 | Israel | 5 | |
#8 | Republic of Korea | 5 | |
#9 | China | 4 | |
#10 | Singapore | 2 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Computer technology | |
#4 | Measurement | |
#5 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Kidd Mark | 38 |
#2 | Drozdov Ignat | 38 |
#3 | Modlin Irvin Mark | 32 |
#4 | Modlin Irvin | 6 |
#5 | Mark Kidd | 5 |
#6 | Ignat Drozdov | 5 |
#7 | Irvin Mark Modlin | 4 |
#8 | Irvin Modlin | 1 |
Publication | Filing date | Title |
---|---|---|
WO2021072035A1 | Compositions, methods and kits for biological sample and rna stabilization | |
WO2019165021A1 | Methods for prostate cancer detection and treatment | |
SG11202006974WA | Methods for colon cancer detection and treatment monitoring | |
EP3717667A1 | Predicting peptide receptor radiotherapy using a gene expression assay | |
CA3067730A1 | Methods for detection of plasma cell dyscrasia | |
CN111315897A | Method for melanoma detection |